
Stay informed on the latest in arthritis prevention, research, treatment and care with JointHealth™ express, Canada's trusted source for arthritis news. Delivered right to your inbox, this "breaking news" bulletin provides timely updates on key arthritis topics, including disease management, research breakthroughs, and treatment advancements. As the longest-running arthritis news source in Canada, JointHealth™ express provides you expert insights from patients and analysis from arthritis health care professionals to help you on your arthritis journey. Stay connected to the arthritis information that matters most.
Click here to see JointHealth™ express bulletins from 2023 and earlier.
Latest News

Arthritis At Home 292 – Uncovering rheumatologic disease in the Northwest Territories

A day to learn, reflect and act – National Day for Truth and Reconciliation

Arthritis at Home 291 – Exploring the results of ACE’s AI and Arthritis National Survey

The Newfoundland and Labrador provincial election is on October 14, 2025. On election day, #Vote4Arthritis

New blog post from Joint Journeys, life with arthritis by Carrie: Six down, six to go!

JointHealth™ insight – September 2025

Arthritis At Home 290 – National Lupus Survey – your voice is needed!

Have your voice heard: National Lupus Survey now open!

Arthritis At Home 289 – Artificial intelligence scribing in rheumatology clinics

Call for patient input on sarilumab (Kevzara®) for polymyalgia rheumatica
Canada’s Drug Agency (CDA-AMC) is currently welcoming patients and their caregivers to provide input to patient organizations on the manufacturer’s ...

Arthritis At Home 288 – Therapeutic cases, CAR-T therapy, and patient advocacy

Call for patient input on obinutuzumab (Gazyva®) for lupus nephritis
Canada’s Drug Agency (CDA-AMC) is currently welcoming patients and their caregivers to provide input to patient organizations on the manufacturer’s ...